1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Cancer

Cancer: Latest Industry Statistics and Treatment Trends

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
21 votes

Global Cancer Treatment Report

The global cancer industry (including treatment of the pathology and the business around it) is one of the most important battle of the 21st century for scientists. According to the World Health Organization, in the late 2010s more than 13% of deaths worldwide are caused by cancer. In fact, the word "cancer" relates to a 100 diseases (i.e. different types of cancer) that are all caused by an uncontrolled division of abnormal cells in a body part. Cancers are usually caused by mutations which may be spontaneous or caused by carcinogens (cancer causing agents). Globally cancers are associated with a high disease burden and are one of the major causes of death.

In a recent year, deaths due to cancers were more than 8 million and the five-year cancer-prevalent population exceeded 30 million. Five-year prevalence population includes patients who have been diagnosed with cancer in the previous five years and who are still alive at the end of a given year.

Cancer can originate in any part of the body. Malignant cancers have the potential to spread to other body parts. There are more than 120 types of cancers affecting humans. The common cancers include breast cancer, prostate cancer, colorectal cancer, lung cancer and cervical cancer. The five-year prevalence population is high for these cancers. Lung cancer, liver cancer, stomach cancer, colorectal cancer and breast cancer are associated with high mortality rates.

Key Segments

The key segments of the cancer market based on cancer type are:

Breast cancer – Breast cancer is the most common cancer in women worldwide, accounting for more than 15% of all female cancer. Breast cancer affected more than 1.5 million globally in a recent year. It begins when abnormal breast cells grow uncontrollably. It can also metastasize (spread) to other organs or tissues. A wide range of treatment options, including surgery, hormonal therapies, chemotherapy, combination therapies, and targeted therapies are administered to treat breast cancer. The global breast cancer therapeutics market is worth about $10 billion.

Lung cancer – Lung cancer (pulmonary carcinoma) is a type of cancer characterized by uncontrolled cell growth in the lungs. It is the fourth most prevalent cancer and has the highest mortality rate. Deaths due to lung cancer were nearly 1.6 million in a recent year. Lung cancers are of two types – small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Over 80% of the lung cancers are NSCLC. Surgery, radiation therapy, chemotherapy and advanced targeted and immunotherapies are used for treating SCLC and NSCLC. The global market for NSCLC will likely exceed $8 billion by 2020.

Colorectal cancer – Colorectal cancer (CRC) is cancer that starts in the colon or rectum. Symptoms do not get apparent until the late stages of tumor development for most CRCs. It is the third most commonly diagnosed gastrointestinal tract cancer and the fourth leading cause of mortality among all cancers. The global colorectal cancer therapeutics market will be worth approximately $10 billion by 2020.

Prostate cancer – Prostate cancer is also known as carcinoma of the prostate. It is usually slow growing and remains symptomless in initial stages. Prostate cancer is the second leading cause of new cancer cases in men worldwide and the sixth leading cause of cancerous death in men. Globally more than 1 million men were diagnosed with prostate cancer in a recent year. The global market for prostate cancer therapeutics is worth about $7 billion.

Regional Market Shares

Major regions in the cancer market include North America, Europe and Asia.

North America is the largest cancer market accounting for more than 40% of the global oncology spend. The USA occupies more about 90% of the North American cancer market. Rising cancer incidence, availability of advanced cancer diagnostics, better treatment access, favorable reimbursement policies and high adoption rate of premium-priced immunotherapies makes the USA occupy the largest market share of global market.

The cancer market in Europe is also significant. A strong pipeline, the expected launch of new cancer therapeutics and high R&D investments are among the key factors in the growth of cancer therapeutics in Europe. The top five cancer markets in Europe are the UK, Germany, France, Spain and Italy.

The cancer market in Asia is growing rapidly. It is likely to grow to grow at a compound annual growth rate of 10% over the next few years. Japan, China and India are among the largest markets for cancer in Asia. Its large patient pool, improving treatment access, increasing government health coverage and improvement in cancer diagnosis are among the key factors driving the cancer market in Asia.

Read more »

You might be interested in these related markets:

Customer Support

Talk to Sam

+33 4 37 65 17 06

460 Reports
Demographic, Company, Demand
2400 Statistics
Demographic, Environment, Market Size
2800 Reports
Demographic, Demand, Social Conditions
12000 Statistics
Demographic, Environment, Social Conditions
160 Reports
Demographic, Demand, Company
1000 Statistics
Demographic, Environment, Demand
170 Reports
Demand, Demographic, Social Conditions
1100 Statistics
Demographic, Demand, Market Size
780 Reports
Demographic, Demand, Social Conditions
6900 Statistics
Demographic, Environment, Social Conditions
61 Reports
Demographic, Social Conditions, Demand
500 Statistics
Demographic, Environment, Social Conditions
290 Reports
Demographic, Social Conditions, Demand
1600 Statistics
Demographic, Environment, Social Conditions
190 Reports
Demographic, Social Conditions, Demand
1100 Statistics
Demographic, Environment, Social Conditions
39 Reports
Demographic, Demand, Social Conditions
540 Statistics
Demographic, Environment, Demand
59 Reports
Demographic, Company Financials, Product Initiative
280 Statistics
Demographic, Environment, Finance
Search in Cancer Industry (About 12000 reports)
Parent industry: Pathology
Related industries: Chronic Disease, Mental Health

About 2800 reports

Purchase Reports From Reputable Market Research Publishers
(From € 200 - € 20000)

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

NHL: Follicular Lymphoma Forecast and Market Analysis to 2025

  • € 20000
  • Industry report
  • April 2018

Follicular lymphoma (FL) is an indolent subtype of non-Hodgkin’s lymphoma (NHL). It is the second most common type of NHL after diffuse large B-cell lymphoma (DLBCL), and accounts for more than 20% of ...

NHL: Diffuse Large B Cell Lymphoma Forecast and Market ... € 20000 April 2018

NHL: Mantle Cell Lymphoma Disease Coverage Forecast and ... € 20000 April 2018

Renal cell cancer (RCC) disease forecast and market ana ... € 20000 February 2018

Prostate Cancer Disease Coverage Forecast and Market An ... € 20000 January 2018

Colorectal Cancer Forecast and Market Analysis to 2036 € 20000 December 2017

Gastric Cancer Forecast and Market Analysis to 2024 € 20000 December 2017

Chronic Myeloid Leukemia (CML) € 20000 December 2017

Multiple Myeloma Disease Coverage Forecast and Market A ... € 20000 October 2017

Cervical Cancer Disease Coverage Forecast and Market An ... € 20000 June 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on